Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SI US Equity

Shoulder Innovations, Inc.Health Care · Surgical & Medical Instruments & Apparatus · CIK 1699350 · FY ends Dec 31
$21.13
+1.21 (+6.07%)
USD · as of 2026-08-18 · marketstack
1 registered study · 1 active

Studies where SI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

1 observational

Held by 7 tracked-famous managers (JANE STREET GROUP, LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, +2 more) · FINRA short interest 2.4 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 3 sells · government filings 180d: none disclosed

StudyPhaseStatusConditionsEnrollmentPrimary completionReadout inUpdated
Shoulder Innovations Clinical Data RegistryNCT06754150observationalDurability of the device component implantRecruitingShoulder Arthroplasty2,500Dec 2039≤ 4,882 d2026-05-11

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19